Day: February 22, 2024

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

Written by Customer Service on February 22, 2024. Posted in Public Companies.

— Fourth quarter 2023 net revenue from global sales of IMCIVREE® (setmelanotide) of $24.2 million — — Enrollment completed in 120-patient, pivotal cohort of Phase 3 setmelanotide trial in hypothalamic obesity; top-line data on track for 1H2025 — — Announced Phase 3 development plans for setmelanotide in hypothalamic obesity in Japan — — Spain and Italy authorities approve reimbursement for IMCIVREE to treat patients with Bardet-Biedl syndrome – — Acquired global rights to oral MC4R agonist LB54640 from LG Chem — — IND application for RM-718 accepted by the FDA – — Management to host conference call today at 8:00 a.m. ET — BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company...

Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Written by Customer Service on February 22, 2024. Posted in Public Companies.

KT-474/SAR444656 (IRAK4) Phase 2 program advancing in HS and AD with data expected in first half of 2025 KT-621 (STAT6) expected to start Phase 1 in second half of 2024 and KT-294 (TYK2) expected to start Phase 1 in first half of 2025, both with Phase 1 data in 2025 Additional KT-333 (STAT3) and KT-253 (MDM2) Phase 1 data expected in 2024 Well-capitalized with $745 million1 in cash as of January 9, 2024, and runway into the first half of 2027 Company to hold call and webcast today at 8:30 a.m. ET WATERTOWN, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided...

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

Written by Customer Service on February 22, 2024. Posted in Public Companies.

DURHAM, N.C., Feb. 22, 2024 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, February 29, 2024 at 8:30 a.m. ET to report financial results for the fourth quarter and full-year ended December 31, 2023, and to provide a business overview. To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 6933453. A live audio webcast of the call will also be available on the Investors’ section of the Company’s website, www.chimerix.com. An archived webcast will be available on the Chimerix...

Glatfelter Reports Fourth Quarter and Year End 2023 Results

Written by Customer Service on February 22, 2024. Posted in Earnings Releases And Operating Results.

~ Q4 performance in-line with expectations despite reduced production to manage inventory levels ~~ Announced plans for Merger with Berry Global’s HHNF business anticipated in second half of 2024 ~ 2023 Fourth Quarter and Year-end Highlights:Generated net sales of $320 million in Q4 and $1.4 billion in 2023; loss from continuing operations of $8.6 million in Q4 and $78.1 million in 2023 Achieved Q4 Adjusted EBITDA of $25 million and full-year EBITDA of $93 million, in-line with Q3 performance and consistent with full year guidance Delivered robust Spunlace performance with $5.7 million Adjusted EBITDA in Q4 and $11.2 million for full year Managed effectively the impact of tornado damage at the Spunlace Tennessee converting operation with minimal disruption to customers; $5 million insurance expense excluded from adjusted earnings Generated...

TransUnion Declares Fourth Quarter 2023 Dividend of $0.105 per Share

Written by Customer Service on February 22, 2024. Posted in Dividend Reports And Estimates.

CHICAGO, Feb. 22, 2024 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash dividend of $0.105 per share for the fourth quarter 2023. The dividend will be payable on March 22, 2024, to shareholders of record on March 7, 2024. About TransUnion (NYSE: TRU) TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As...

Armada Hoffler Reports Fourth Quarter and Full Year 2023 Results

Written by Customer Service on February 22, 2024. Posted in Dividend Reports And Estimates.

Net Loss of $0.27 per Diluted Share for the Fourth Quarterand $0.05 per Diluted Share for the Full Year Normalized FFO of $0.31 per Diluted Share for the Fourth Quarterand $1.24 per Diluted Share for the Full Year Announced 5% Increase in the Quarterly Cash Dividend on Common Stock Dividends Declared During the Year Represent a 7.6% Year-Over-Year Increase Introduced 2024 Full-Year Normalized FFO Guidance Range of $1.21 to $1.27 per Diluted Share VIRGINIA BEACH, Va., Feb. 22, 2024 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (NYSE: AHH) today announced its results for the quarter and year ended December 31, 2023 and provided an update on current events. Highlights include:Net loss attributable to common stockholders and OP Unitholders of $23.9 million and $4.5 million for the three months and year ended December 31, 2023,...

THOR Industries Announces Date For Its Fiscal 2024 Second Quarter Earnings Release

Written by Customer Service on February 22, 2024. Posted in Public Companies.

ELKHART, Ind., Feb. 22, 2024 (GLOBE NEWSWIRE) — THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2024 second quarter earnings release will be on Wednesday, March 6, 2024 before the market opens. Upon the release of THOR’s fiscal 2024 second quarter earnings, the Company will concurrently publish a copy of the earnings release, a comprehensive question and answer document and a slide presentation on the Company’s website. To view the quarterly earnings documents, please go to http://ir.thorindustries.com/. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world’s largest manufacturer of recreational vehicles. For more information on the Company and its products, please go to www.thorindustries.com. Forward-Looking Statements This...

Banco Santander Chile Announces the Filing of Its Annual Report on Form 20-F With the United States Securities and Exchange Commission for Fiscal Year 2023

Written by Customer Service on February 22, 2024. Posted in Public Companies.

SANTIAGO, Chile, Feb. 22, 2024 (GLOBE NEWSWIRE) — Banco Santander Chile (“Santander Chile” or the “Company”) (NYSE: BSAC; SSE: Bsantander) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “2023 Annual Report”) has been filed with the U.S. Securities and Exchange Commission (the “SEC”). The 2023 Annual Report can be accessed either by visiting the SEC’s website at www.sec.gov or Santander Chile’s corporate website at www.santander.cl. In addition, shareholders may receive a hard copy of the 2023 Annual Report, which includes the Company’s complete audited financial statements, free of charge by requesting a copy from Santander Chile’s Investor Relations Office by email at: irelations@santander.cl. CONTACT INFORMATIONInvestor RelationsBanco Santander ChileBandera...

Prairie Provident Announces Year-End 2023 Reserves

Written by Customer Service on February 22, 2024. Posted in Public Companies.

CALGARY, Alberta, Feb. 22, 2024 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident” or the “Company”) (TSX: PPR) is pleased to announce the results of its December 31, 2023 independent reserves evaluation (the “Sproule Report”) conducted by Sproule Associates Limited (“Sproule”). The Sproule Report highlights that despite minimal capital spending, reserves additions were realized year-over-year driven primarily by positive technical revisions associated with lower fixed costs, reactivations, and optimizations. A 16-year reserve life index on total proved reserves underscores the potential of the assets to deliver meaningful growth and shareholder value.2023 Reserves Highlights(1)December 31, 2023 Proved Developed Producing Total Proved Total Proved plus ProbableReserves (MMboe) 9.4 21.1 30.1Net...

Radisson Appoints Brett A. Richards as President & Chief Executive Officer and Director

Written by Customer Service on February 22, 2024. Posted in Public Companies.

ROUYN-NORANDA, Quebec, Feb. 22, 2024 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTCQB: RMRDF) (“Radisson” or the “Company”) is pleased to announce the appointment of Brett A. Richards as President and Chief Executive Officer, effective April 1st, 2024, taking over from Interim President & CEO, Denis V. Lachance, who will remain Chair of Radisson’s Board of Directors. Effective February 22, 2024, Brett will also join the Board of Radisson as a director. Mr. Richards is an experienced and accomplished natural resources executive with over 37 years in executive, senior, and operational management in the mining and metals industry. He is a high-energy, results-driven leader with world-wide business experience on 5 continents and in over 30 countries. Mr. Richards has served as the CEO of several London LSE...

Day: February 22, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice